Agnieszka Wieclawek

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report

G. Helbig, S. Kyrcz‐Krzemień, K. Woźniczka, 2014, Contemporary oncology.

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome

G. Helbig, S. Kyrcz‐Krzemień, M. Hus, 2012, Medical Oncology.

Very poor outcome of leukemic transformation in myelofibrosis: a single center experience with 13 patients

G. Helbig, A. Rusek, S. Kyrcz‐Krzemień, 2012, Leukemia & lymphoma.